Adipotide

Adipotide — frequently asked questions

• What is Adipotide?

  Adipotide, also known as FTPP (Fat Targeted Proapoptotic Peptide), is an experimental peptide designed to induce targeted apoptosis of fat cells, potentially resulting in rapid reduction of body fat in animal studies.

• What is the half-life of Adipotide?

  Adipotide has an approximate half-life of 2–4 hours (in animal studies; human data not established). The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.

• How is Adipotide administered?

  Adipotide is typically delivered via subcutaneous injection (for research use only). The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.

• How does Adipotide work?

  Adipotide targets specific proteins on the surface of fat cell blood vessels (Prohibitin and ANXA2), causing apoptosis (cell death) in the blood vessels supplying white adipose tissue. This leads to fat cell death and subsequent reduction of fat mass.

• What are the researched benefits of Adipotide?

  Studied benefits of Adipotide include: Rapid fat loss observed in animal studies, Reduces white adipose tissue, Potential metabolic improvements (e.g., insulin sensitivity), Non-stimulant fat loss mechanism. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.

• What are the side effects of Adipotide?

  Reported side effects of Adipotide include: Dehydration, Mild to moderate kidney stress (noted in primate studies), Electrolyte imbalance, Potential for nausea, lethargy, and other systemic effects. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.